DocDollars

Assertio Therapeutics, Inc.

IL · United States · Reporting entity ID 100000000324

Total reported 2019–2025
$834K
#1,383 of 2,960 reporting companies — 0% of all reported industry payments
$278K in general payments across 11,459 records, plus $556K in research funding across 9 records.

How it breaks down

General payments $277,825
Research funding $556,294

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Assertio Therapeutics, Inc. reported $834K to US doctors and teaching hospitals from 2019 to 2025, ranking #1,383 of 2,960 reporting companies. 67% of that was research funding and 33% general payments such as consulting, speaking, food and travel. 11,459 general payment records and 9 research records were filed.

Common questions about Assertio Therapeutics, Inc.

How much has Assertio Therapeutics, Inc. paid US doctors?

Assertio Therapeutics, Inc. reported $834,118 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $277,825 in general payments, $556,294 in research funding.

How does Assertio Therapeutics, Inc. rank among drug and device companies?

It ranks #1,383 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Assertio Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.